World's Best Scientists 2026 revealed!
Giovanni Cazzaniga

Giovanni Cazzaniga

D-Index & Metrics

Biology and Biochemistry

D-Index
77
Citations
26067
World Ranking
4711
National Ranking
104

Giovanni Cazzaniga publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Giovanni Cazzaniga sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 377 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Giovanni Cazzaniga D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Giovanni Cazzaniga sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 77 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Giovanni Cazzaniga is affiliated with the University of Milano-Bicocca in Italy. Their research spans a broad spectrum within medicine, with a particular focus on hematology and molecular biology. Their work addresses significant areas such as acute lymphoblastic leukemia (ALL), acute myeloid leukemia, chronic myeloid leukemia, and chronic lymphocytic leukemia, as well as topics related to childhood cancer survivors' quality of life and CAR-T cell therapy research.

Their publication record is strong in leading journals, with frequent contributions to Blood, Leukemia, HemaSphere, Experimental Hematology, and the International Journal of Molecular Sciences.

Among recent notable papers authored or co-authored by Giovanni Cazzaniga are:

  • The KMT2A recombinome of acute leukemias in 2023, Leukemia
  • Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities, 2020, Journal of Clinical Investigation
  • Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study, 2021, Leukemia
  • The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia, 2021, International Journal of Molecular Sciences
  • Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium, 2021, Blood

Frequent collaborators include several researchers with whom Giovanni Cazzaniga has co-authored numerous publications, including:

  • Andrea Biondi
  • Grazia Fazio
  • Maria Grazia Valsecchi
  • Michela Bardini
  • Chiara Palmi

Their work integrates diverse subfields such as public health, environmental and occupational health, hematology, molecular biology, genetics, and oncology. This interdisciplinary approach supports their contributions to fields like acute leukemia research and cancer treatment strategies, including the development and investigation of CAR-T cell therapies.

Best Publications

  • Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program

    J Gabert;E Beillard;V H J van der Velden;W Bi

  • Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

    Jacques Jm van Dongen;Taku Seriu;E Renate Panzer-Grümayer;Andrea Biondi

  • Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

    Valentino Conter;Claus R. Bartram;Maria Grazia Valsecchi;Andre Schrauder

  • Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data.

    V H J van der Velden;G Cazzaniga;A Schrauder;J Hancock

  • Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

    V H J van der Velden;A Hochhaus;G Cazzaniga;T Szczepanski

  • Prenatal origin of acute lymphoblastic leukaemia in children

    JL Wiemels;G Cazzaniga;M Daniotti;OB Eden

  • The MLL recombinome of acute leukemias in 2013

    C. Meyer;J. Hofmann;T. Burmeister;D. Gröger

  • Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study

    Martin Schrappe;Maria Grazia Valsecchi;Claus R. Bartram;André Schrauder

  • Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia.

    T Flohr;T Flohr;A Schrauder;G Cazzaniga;R Panzer-Grümayer

  • Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia

    Elisabetta Flex;Valentina Petrangeli;Lorenzo Stella;Sabina Chiaretti

  • RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia

    Elli Papaemmanuil;Inmaculada Rapado;Yilong Li;Nicola E Potter

  • Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias

    Chen Shochat;Noa Tal;Noa Tal;Obul R. Bandapalli;Obul R. Bandapalli;Chiara Palmi

  • Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

    Dani Bercovich;Ithamar Ganmore;Linda M. Scott;Gilad Wainreb

  • Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials

    Arndt Borkhardt;Giovanni Cazzaniga;Susanne Viehmann;Maria Grazia Valsecchi

  • Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML.

    Brunangelo Falini;Niccolò Bolli;Jing Shan;Maria Paola Martelli

  • Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations

    Paolo Gorello;G. Cazzaniga;F. Alberti;M. G. Dell'Oro

  • Genetic evidence for lineage-related and differentiation stage–related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia

    Marco Tartaglia;Simone Martinelli;Giovanni Cazzaniga;Viviana Cordeddu

  • Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

    Libi Hertzberg;Libi Hertzberg;Libi Hertzberg;Elena Vendramini;Ithamar Ganmore;Ithamar Ganmore;Giovanni Cazzaniga

  • Molecular Analysis of the Progression from Helicobacter pylori–Associated Chronic Gastritis to Mucosa-Associated Lymphoid-Tissue Lymphoma of the Stomach

    Emanuele Zucca;Francesco Bertoni;Enrico Roggero;Giovanna Bosshard

  • Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia

    Cornelia Eckert;Andrea Biondi;Karlheinz Seeger;Giovanni Cazzaniga

Frequent Co-Authors

Andrea Biondi
Andrea Biondi University of Milano-Bicocca
Giuseppe Basso
Giuseppe Basso University of Padua
Maria Grazia Valsecchi
Maria Grazia Valsecchi University of Milano-Bicocca
Martin Schrappe
Martin Schrappe Kiel University
Martin Stanulla
Martin Stanulla Hannover Medical School
Hélène Cavé
Hélène Cavé Université Paris Cité
Mel Greaves
Mel Greaves Institute of Cancer Research
Jan Trka
Jan Trka Charles University
Oskar A. Haas
Oskar A. Haas Medical University of Vienna
Andrea Pession
Andrea Pession University of Bologna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Biology or Biochemistry opens the door to a variety of career options beyond research and clinical roles. There is growing demand for professionals who blend science with technology and data management in healthcare. If you’re interested in pivoting toward healthcare administration, consider the online health information management degree as an affordable and flexible pathway.

Medical coding and billing careers are also popular choices for science graduates. There are different medical coding certification options, such as CPC and CCS, each with costs and salary prospects you’ll want to compare. If you are wondering how long does it take to become a medical coder, the process can be completed in a matter of months with the right training.

Many find this field rewarding, but you may also want to explore whether is medical coding a good job for your interests and long-term growth. Whichever path you choose, online programs offer the flexibility to upskill while building on your scientific background.

Best Scientists Citing Giovanni Cazzaniga

Trending Scientists

Recently Published Articles